RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Huaren Pharmaceutical Co Stock

Huaren Pharmaceutical Co P/S 2025

Huaren Pharmaceutical Co P/S

2.99

Ticker

300110.SZ

ISIN

CNE100000SW1

As of Feb 11, 2025, Huaren Pharmaceutical Co's P/S ratio stood at 2.99, a 12.83% change from the 2.65 P/S ratio recorded in the previous year.

The Huaren Pharmaceutical Co P/S history

Huaren Pharmaceutical Co Aktienanalyse

What does Huaren Pharmaceutical Co do?

Huaren Pharmaceutical Co. Ltd is a leading Chinese pharmaceutical company based in Beijing. It was founded in 1996 and has since experienced impressive growth. The company is listed on the Shanghai Stock Exchange under the ticker symbol SHA:600664. Huaren Pharmaceutical's history is characterized by a smart corporate strategy and a strong focus on customer needs. The company started as a small family business and built a strong presence in the Chinese market in the following years. This involved establishing innovative strategic partnerships with other companies in the industry. In 2010, the company went public, further accelerating its growth. The business model of Huaren Pharmaceutical is based on a wide product portfolio, including various products in the pharmaceutical, healthcare, and biotechnology industries. The company works closely with international experts and scientific institutes to ensure the highest quality and effectiveness of its products. It is active in research and development, production, and distribution of healthcare products and services, and has built strong industry expertise. The different divisions of Huaren Pharmaceutical include the production of antibiotics, vitamin complexes, painkillers, and vaccines. The company is also involved in diagnostic, hospital care, and medical device sectors. Another important division is the production of generics, which makes the company one of the major players in the Chinese generic drug market. Huaren Pharmaceutical takes pride in providing a comprehensive range of products for patients. Its key products include anti-cancer therapies, medications for nervous system disorders, cardiovascular diseases, and vascular diseases. The company has state-of-the-art research and development departments that ensure its products are always at the forefront of technology and meet customer needs. Due to its innovation capabilities, Huaren Pharmaceutical has won numerous awards and patents. The company aims to solidify its market leadership in China while expanding its presence in the Asian and global pharmaceutical markets. It also intends to focus on the biotechnology market and expand its research and development activities. With this strategic approach, Huaren Pharmaceutical aims to remain a significant player in the Chinese pharmaceutical industry and drive advancements and technologies in healthcare. Huaren Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Huaren Pharmaceutical Co's P/S Ratio

Huaren Pharmaceutical Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Huaren Pharmaceutical Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Huaren Pharmaceutical Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Huaren Pharmaceutical Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Huaren Pharmaceutical Co stock

What is the price-to-earnings ratio of Huaren Pharmaceutical Co?

The price-earnings ratio of Huaren Pharmaceutical Co is currently 2.99.

How has the price-earnings ratio of Huaren Pharmaceutical Co changed compared to last year?

The price-to-earnings ratio of Huaren Pharmaceutical Co has increased by 12.83% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Huaren Pharmaceutical Co high compared to other companies?

Yes, the price-to-earnings ratio of Huaren Pharmaceutical Co is high compared to other companies.

How does an increase in the price-earnings ratio of Huaren Pharmaceutical Co affect the company?

An increase in the price-earnings ratio of Huaren Pharmaceutical Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Huaren Pharmaceutical Co affect the company?

A decrease in the price-earnings ratio of Huaren Pharmaceutical Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Huaren Pharmaceutical Co?

Some factors that influence the price-earnings ratio of Huaren Pharmaceutical Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Huaren Pharmaceutical Co pay?

Over the past 12 months, Huaren Pharmaceutical Co paid a dividend of 0.02 CNY . This corresponds to a dividend yield of about 0.63 %. For the coming 12 months, Huaren Pharmaceutical Co is expected to pay a dividend of 0.02 CNY.

What is the dividend yield of Huaren Pharmaceutical Co?

The current dividend yield of Huaren Pharmaceutical Co is 0.63 %.

When does Huaren Pharmaceutical Co pay dividends?

Huaren Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of July, July, August, August.

How secure is the dividend of Huaren Pharmaceutical Co?

Huaren Pharmaceutical Co paid dividends every year for the past 7 years.

What is the dividend of Huaren Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.02 CNY are expected. This corresponds to a dividend yield of 0.63 %.

In which sector is Huaren Pharmaceutical Co located?

Huaren Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Huaren Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Huaren Pharmaceutical Co from 7/10/2024 amounting to 0.021 CNY, you needed to have the stock in your portfolio before the ex-date on 7/10/2024.

When did Huaren Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/10/2024.

What was the dividend of Huaren Pharmaceutical Co in the year 2024?

In the year 2024, Huaren Pharmaceutical Co distributed 0.018 CNY as dividends.

In which currency does Huaren Pharmaceutical Co pay out the dividend?

The dividends of Huaren Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Huaren Pharmaceutical Co

Our stock analysis for Huaren Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Huaren Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.